Alzheimer’s for Amateurs

19 November 2026 edition

The Ozempic Pill Didn’t Slow Alzheimer’s

Read it on Substack
A box of Rybelsus 14 mg semaglutide tablets beside a blue blister pack and a tape measure on a cracked concrete floor.
Edugrafo / Shutterstock.com

What’s inside

The Answer

Two big trials, one clear answer

Two final-stage trials gave the semaglutide pill, the drug inside Ozempic, two years in 3,808 people with early Alzheimer’s. An inflammation marker fell, but memory and daily life declined at the same pace as on a placebo.

Trial Watch

Lithium orotate’s first test, and two pills that missed

Johns Hopkins expects to open LiO-AD on December 1, the first real test of the supplement. At CTAD, AR1001 missed its main goal overall and PRI-002 missed.

Roundup

A gentler start, a stroke warning, a vaccine

A slower start for donanemab cut brain swelling by about a third, risperidone was linked to more strokes, and a prevention vaccine got FDA Fast Track.

Spotted in the Wild

The creatine pitch, checked

A clip about creatine for the brain passed 1.1 million views. The evidence so far is small, and the trial that would settle it hasn’t been done.